Nearly 64% of adults need vision correction, including eyeglasses, contact lenses, and undergo surgeries. In the U.S. approximately 63% of people use corrective eyewear, among which 76% of people are aged 45 to 64. This rise in the use of eyewear and growing awareness regarding UV rays has promoted the uptake of eyewear, which is one of the chief drivers of morpholine market growth. Furthermore, the increasing number of people suffering from eye diseases and vision disparities will positively influence product adoption.
Authors:
Kiran Pulidindi, Kunal Ahuja
Frequently Asked Questions (FAQ) :
The market size of morpholine valued at more than USD 3.5 billion in 2022 and will progress at a 6% CAGR between 2023 and 2032 propelled by increasing application in corrosion inhibitors.
The diethanolamine segment accounted for more than USD 2 billion in 2022 as a result of the expansion of the cosmetic industry and changing beauty standards.
The optical brighteners application segment will depict over 6% CAGR from 2023 to 2032 owing to its use as a chemical polishing agent on glass and other optical parts to provide enhanced luster and purity on their surface.
Asia Pacific industry size reached USD 0.95 billion in 2022, attributed to the availability of raw materials such as ethylene oxide and ammonia for the production of morpholines in the region.